Large multi-country cohorts, tight enrollment windows, multi-dose schedules, and cold-chain supply across hundreds of sites. Our RTSM technology and experts are built to hold that complexity, from first participant in to database lock.
30 years of RTSM experience across vaccine and infectious disease programs worldwide.
The products and expertise we bring to vaccine and infectious disease trials, from large-scale randomization and cold-chain supply through to eCOA and study-design consultancy.
Solutions
Our next-generation unified RTSM / IRT platform. Randomization, participant management, drug supply, and reporting in one connected system, built for large multi-country vaccine trials and event-driven infectious disease designs.
Learn MoreStreamlined, ready-to-deploy RTSM on the same platform and quality framework, with go-live in about four weeks. A right-fit option for early-phase vaccine studies and lean infectious disease programs that need proven capability fast.
Learn MoreElectronic Clinical Outcome Assessment through our Kayentis partnership, available as an integrated RTSM plus eCOA solution to capture participant diaries and symptom data alongside randomization and dosing.
Learn MoreSupply-chain and randomization consultancy plus expert training, designed to de-risk stratified, multi-country vaccine designs before and during the study.
Learn MoreServices
End-to-end RTSM design, implementation, integration, validation, deployment, and support for vaccine and infectious disease protocols, delivered by an embedded team of experts.
Learn MoreExpert design of randomization and stratification strategy for age-stratified, multi-country, and placebo-controlled vaccine protocols.
Learn MoreForecasting and supply modeling to reduce waste and protect continuity of cold-chain and frozen IMP across large site networks.
Learn MoreThe four capability areas behind every study we run, applied to the specific demands of vaccine and infectious disease clinical trials.
Blocked, stratified, and dynamic randomization across age cohorts, sites, and countries in large placebo-controlled vaccine trials.
Forecast-driven resupply, depot-to-site logistics, and lot and expiry management for cold-chain and frozen vaccine IMP at scale.
Site activation at volume, dosing-visit windows, participant replacement, and emergency unblinding across multi-dose schedules.
Audit trails, data-change reporting, and real-time dashboards designed to support inspection readiness for vaccine submissions.
A look at how standardized configurations and expert support shortened study start-up — and what teams running Phase II and III trials can take from it.
July 24, 2026
Talk with our RTSM experts about the randomization, drug-supply, and data challenges specific to your vaccine or infectious disease protocol.
